Pediatric Clinical Trial
Official title:
Phase 1, Open-label, Multiple-dose, and Age De-escalation Trial to Assess the Pharmacokinetics, Safety and Tolerability of Delamanid (OPC 67683) in Pediatric Multidrug-resistant Tuberculosis Patients on Therapy With an Optimized Background Regimen of Anti-tuberculosis Drugs
The purpose of this trial is to determine the pediatric dose of delamanid that is equivalent to the adult dose already shown to be effective against multidrug-resistant tuberculosis.
This trial will investigate the pharmacokinetics (PK) and safety of delamanid administered
for 10 days to pediatric patients aged birth to 17 years who are also on therapy with an
optimized background regimen. The purpose of the trial is to determine which dose in
pediatric MDR-TB patients will result in delamanid plasma exposure similar to efficacious
plasma exposure in adult MDR-TB patients. This is an age de-escalation trial in four groups:
Group 1: 12 to 17 years (100 mg BID; n=6) Group 2: 6 to 11 years (50 mg BID; n=6) Group 3: 3
to 5 years (25 mg BID; n=12) Group 4: Birth to 2 years (Dose based on patient's body weight,
n=12)
- Patients > 10 kg will receive 10 mg BID
- Patients > 8 kg and ≤ 10 kg will receive 5 mg BID
- Patient ≤ to 8 kg will receive 5 mg QD
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04176822 -
Designing Animated Movie for Preoperative Period
|
N/A | |
| Completed |
NCT01981954 -
A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)
|
Phase 3 | |
| Completed |
NCT02199626 -
SECOND GENERATION COLON CAPSULE ENDOSCOPY (CCE-2) IN PEDIATRIC CROHN'S DISEASE (CD).
|
Phase 4 | |
| Recruiting |
NCT04679792 -
Postual Control in Pediatric Chiari I Malformation
|
||
| Recruiting |
NCT06061159 -
The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction
|
Phase 4 | |
| Active, not recruiting |
NCT05453968 -
Berotralstat Treatment in Children With Hereditary Angioedema
|
Phase 3 | |
| Not yet recruiting |
NCT02182648 -
Bispectral Index Guiding Etomidate Used in Children Aged 3 to 10 for Clinical Anesthesia Induction
|
Phase 4 | |
| Active, not recruiting |
NCT04176640 -
Quantifying Brain Injury on Computed Tomography in Hospitalized Children
|
||
| Active, not recruiting |
NCT06146452 -
Micronutrient Status in Pediatric Palliative Care
|
||
| Completed |
NCT04041180 -
Impact on the Length of Stay in Incentive Spirometry and Pain in the Decompensation of Sickle Cell Disease: .
|
||
| Not yet recruiting |
NCT06165003 -
Examination of Nurses' Use of Broselow Tape in Non-resuscitation Pediatric Emergency Department Practices
|
N/A | |
| Recruiting |
NCT02286297 -
Pediatric Endotracheal Intubation During Resuscitation
|
N/A | |
| Unknown status |
NCT00613184 -
Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses
|
N/A | |
| Recruiting |
NCT00265772 -
Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis
|
Phase 4 | |
| Completed |
NCT04106063 -
A New Speech, Spatial, and Qualities of Hearing Scale Short-Form for Deaf Children
|
||
| Not yet recruiting |
NCT06376643 -
Augmented Reality to Support Cardiopulmonary Resuscitation
|
N/A | |
| Not yet recruiting |
NCT05511233 -
ERAS Protocol in Newborns: CARES Study
|
N/A | |
| Not yet recruiting |
NCT04127968 -
Efficacy and Safety of Vitamin A Treatment for Children With Sepsis
|
N/A | |
| Active, not recruiting |
NCT04472286 -
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors
|
||
| Recruiting |
NCT04988516 -
Virtual Reality Distraction for Anxiety (VR-IMAGINE)
|
N/A |